ICHIKAWA; Kimihisa

Patent Applications and Registrations

Patent applications and USPTO patent grants for ICHIKAWA; Kimihisa.The latest application filed is for "method for improved high-level secretory production of protein".

Company Profile

0.15.23

ICHIKAWA; Kimihisa - Oura-gun JP
Ichikawa; Kimihisa - Kanagawa-ken JP
Ichikawa; Kimihisa - Tokyo JP
Ichikawa; Kimihisa - Edogawa-ku N/A JP
Ichikawa; Kimihisa - Yokohama-shi JP
Ichikawa; Kimihisa - Yokohama JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Improved High-level Secretory Production Of Protein App 20170211063 - NONAKA; Koichi ; et al.	2017-07-27
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 9,700,618 - Zhou , et al. July 11, 2	2017-07-11
Dr5 Ligand Drug Conjugates App 20150079114 - Ohtsuka; Toshiaki ; et al.	2015-03-19
Antibody Selective For A Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor And Uses Thereof App 20140308288 - Zhou; Tong ; et al.	2014-10-16
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof Grant 8,715,668 - Zhou , et al. May 6, 2	2014-05-06
Dr5 Ligand Drug Conjugates App 20130280282 - Ohtsuka; Toshiaki ; et al.	2013-10-24
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20130243780 - Zhou; Tong ; et al.	2013-09-19
Method for high-level secretory production of protein Grant 8,409,825 - Chiba , et al. April 2, 2	2013-04-02
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 8,329,180 - Zhou , et al. December 11, 2	2012-12-11
Method for high-level secretory production of protein Grant 8,232,377 - Chiba , et al. July 31, 2	2012-07-31
Antibody Selective For A Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor And Uses Thereof App 20120076792 - Zhou; Tong ; et al.	2012-03-29
Antibodies Modified With Hydrophobic Molecule App 20110269942 - Morita; Koji ; et al.	2011-11-03
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,981,421 - Zhou , et al. July 19, 2	2011-07-19
Dr5 Ligand Drug Conjugates App 20110070248 - Ichikawa; Kimihisa ; et al.	2011-03-24
Method For High-level Secretory Production Of Protein App 20110014651 - Chiba; Yasunori ; et al.	2011-01-20
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20110008324 - Zhou; Tong ; et al.	2011-01-13
Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents App 20110002887 - Kimberly; Robert P. ; et al.	2011-01-06
Antibody against tumor specific antigen as target Grant 7,855,056 - Ichikawa , et al. December 21, 2	2010-12-21
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 7,790,165 - Zhou , et al. September 7, 2	2010-09-07
Immunoliposome Inducing Apoptosis Into Cell Expressing Death Domain-containing Receptor App 20100209490 - Morita; Koji ; et al.	2010-08-19
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,704,502 - Zhou , et al. April 27, 2	2010-04-27
Method For High-level Secretory Production Of Protein App 20090191587 - Chiba; Yasunori ; et al.	2009-07-30
Combinations of Antibodies Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Other Therapeutic Agents App 20090022707 - Kimberly; Robert P. ; et al.	2009-01-22
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20070298039 - Zhou; Tong ; et al.	2007-12-27
Combinations of DR5 antibodies and other therapeutic agents Grant 7,279,160 - Zhou , et al. October 9, 2	2007-10-09
Antibody against tumor specific antigen as target App 20070166312 - Ichikawa; Kimihisa ; et al.	2007-07-19
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 7,244,429 - Zhou , et al. July 17, 2	2007-07-17
Oculospanin as a tumor specific antigen and methods and compositions utilizing same App 20070025996 - Ichikawa; Kimihisa ; et al.	2007-02-01
Anti-Fas antibodies Grant 6,972,323 - Serizawa , et al. December 6, 2	2005-12-06
Pharmaceutical compositions containing anti-Fas antibody Grant 6,746,673 - Serizawa , et al. June 8, 2	2004-06-08
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030190687 - Zhou, Tong ; et al.	2003-10-09
Anti-Fas antibodies App 20030170817 - Serizawa, Nobufusa ; et al.	2003-09-11
Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents App 20030133932 - Zhou, Tong ; et al.	2003-07-17
Anti-fas antibodies App 20030103976 - Serizawa, Nobufusa ; et al.	2003-06-05
Pharmaceutical compositions containing anti-fas antibody App 20020103212 - Serizawa, Nobufusa ; et al.	2002-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.